Hungary prepared the vaccine against H5N1 virus

An employee of the Omnivest laboratory held an H5N1 vaccine on March 14, Hungary announced that it had successfully prepared a vaccine against the H5N1 virus. Meanwhile, bird flu continues to spread rapidly.

This anti-H5N1 vaccine is made by Hungarian pharmaceutical company Omnivest, which has the potential to help people become immune to H5N1. Prime Minister Ferenc Gyurcsany said that if the bird flu virus spreads at chicken farms, 20,000 people including veterinarians, poultry farmers, and poultry contacts will be vaccinated with the vaccine daily. The Hungarian National Institute of Materials (OGYI) has given the green light for the production and sale of this vaccine, and is ready to sell vaccine recipes to countries.

Meanwhile, France's Sanofi-Aventis pharmaceutical group (which is building a vaccine against bird flu), believes that the vaccine produced by hungary " does not meet European requirements" so the vaccine only valid in Hungary.

An Indian health worker disinfects stables in Maharashtra

Elsewhere, India announced the discovery of a new outbreak of bird flu with four samples of H5N1 in four villages in Jalgaon, north of Maharashtra state. The cases infected with this H5N1 virus were discovered about 140 km from the first outbreak. The government decided to kill more than 75,000 poultry in the area to prevent spread.

In Afghanistan, the government has confirmed that the H5N1 avian influenza virus exists in Kabul and the eastern province of Nangarhar. So far, five poultry samples carry the H5 virus but have not yet identified the virus